This project focuses on developing a software tool to help comprehend the impact of the time and size of an insulin bolus to regulate post prandial glucose excursion in blood for people with Type 1 ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

Real-world use of the MiniMed 780G (MM780G) system is associated with effective glycemic control on days when users do not administer bolus insulin, achieving a mean time in range of 70.9%. Real-world ...

COPENHAGEN, Denmark & PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, ...

Insulin type, mixture of insulins in the same syringe, site of injection, and individual patient response differences can all affect the onset, peak, and duration of insulin activity. In general, ...